Acura ends all Aversion litigation with final Sandoz settlement

23-05-2014

Acura ends all Aversion litigation with final Sandoz settlement

Illustration: Andrea Danti / Shutterstock.com

US-based drug company Acura and Novartis’s generic arm Sandoz have settled their patent infringement dispute related to an abuse-deterrent formulation of the painkiller Aversion (oxycodone).


Acura, Sandoz, Aversion, Oxecta, patent settlement

LSIPR